Sector valuations Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,566.10 INR | +1.96% |
|
-2.11% | +39.61% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 36.58x | 5.13x | 2.64x | 6.94x | 23.91x | 28.97x | 0.88% | 5TCr | |
| 17.89x | 1.79x | -1.9x | 2.07x | 9.55x | 12.45x | 1.4% | 3.66TCr | |
| 28.68x | 3.17x | 4.08x | 3.5x | 18.13x | 23.24x | 0.87% | 1.25TCr | |
| 26.71x | 3.67x | -1.69x | 3.94x | 16.04x | 21.96x | 0.59% | 1.18TCr | |
| 19x | 3.24x | 5.6x | 3.32x | 11.92x | 14.25x | 3.5% | 903.81Cr | |
| 15.69x | 1.27x | 6.78x | 2.02x | 6.33x | 9.52x | 3.29% | 702.99Cr | |
| 8.24x | 1.42x | 0.65x | 1.93x | 5.06x | 6.13x | 5.26% | 679.37Cr | |
| 33.91x | 6x | 0.44x | 3.86x | 16.43x | 18.14x | 0.24% | 660.39Cr | |
| 41.33x | 9.5x | 2.94x | 7.92x | 29.37x | 32.79x | 0.96% | 453.34Cr | |
| 15.98x | 2.6x | 0.69x | 2.58x | 12.02x | 11.64x | 3.33% | 404.47Cr | |
| 15.33x | 0.74x | -0.03x | 2.1x | 9x | 11.43x | 1.77% | 400.12Cr | |
| 12.91x | - | 3.2x | 10.41x | 9.67x | 9.9x | - | 277.66Cr | |
| 13.34x | 2.69x | 1.11x | 3.09x | 11.55x | 12.76x | 2.97% | 265.42Cr | |
| 18.41x | 4.93x | 1.51x | 5.73x | 16.3x | 17.63x | 3.27% | 255.35Cr | |
| 30.43x | - | -0.12x | - | - | - | - | 234.4Cr | |
| Average | 22.30x | 3.55x | 1.73x | 4.24x | 13.95x | 16.49x | 2.18% | 1.09TCr | |
| Weighted average by Cap. | 25.86x | 3.60x | 1.41x | 4.36x | 15.99x | 19.63x | 1.56% |
Select your edition
All financial news and data tailored to specific country editions
